Cargando...
LCZ696 (sacubitril/valsartan) for patients with heart failure
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess benefits and harms of first‐in‐class angiotensin receptor‐neprilysin inhibitor sacubitril/valsartan (LCZ696) as compared to angiotensin‐converting enzyme inhibitors (ACEI) or angiotensin II receptor blo...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2020
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984414/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013517 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|